Smith & Nephew Knee Implants:
In August 2003, Smith & Nephew's Orthopedic division alerted the Food and Drug Administration (FDA) following the discovery of a Oxinium product defect. The defect was a design and function flaw that did not allow the macrotexturing surface to provide proper bonding to the bone with its cementless design. Then in September 2003, Smith & Nephew's Orthopedic division voluntarily issued a recall on the Oxinum Cementless Knee Replacements.

What are the Recalls?
The recall was on the cementless versions of :

• Oxinium Genesis II
• Profix II
  

The patients who have received these devices could be at a higher risk of further joint and/or muscular damage, along with re-infection when compared to those who have received other knee implant devices.